Greenwich LifeSciences, Inc.

NASDAQ:GLSI

Biotechnology

Healthcare
$20.58 -3.08%

-$0.74 today

Market cap
$302.08M
Beta
1.38
P/E (TTM)
-15.6
EPS (TTM)
-$1.49
52W Low $7.78High $34.10

Volume 0.71M

Average 0.14M

GLSI EBITDA Margin

EBITDA as a percentage of revenue.

No reported EBITDA Margin figures are available to summarize.

EBITDA Margin history

Percent of revenue · from the income statement

No EBITDA Margin data reported for this period type.

EBITDA Margin vs competitors

How GLSI compares with its peers on the latest reported figures

GLSI Competitors Peer median
EBITDA Margin for GLSI and competitors
Company Period LTM level YoY 3-year change
AGENAgenus Inc.LTM Mar 2026102.6% +184.0 pp+219.6 pp
SEERSeer, Inc.LTM Mar 2026-427.9% +95.5 pp+175.4 pp
IRDOpus Genetics, Inc.LTM Mar 2026-874.0% -638.6 pp-384.3 pp
SRZNSurrozen, Inc.LTM Mar 2026-4567.0% -3876.5 pp-6672.9 pp
GLSIGreenwich LifeSciences, Inc.FY2025— ——
IMMXImmix Biopharma, Inc.FY2025— ——
HURATuHURA Biosciences, Inc.FY2025— ——
CGTXCognition Therapeutics, Inc.FY2025— ——
ONCYOncolytics Biotech Inc.FY2025— ——
Peer median (excluding GLSI) -650.9%-271.6 pp-104.5 pp

Competitors are the stored peer set for GLSI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue3.61K3.61K3.61K3.61K1.78K
Gross Profit(3.61K)(3.61K)(3.61K)(3.61K)(1.78K)
Gross Margin—————
Research & Development3.56M6.48M7.7M15.48M17.22M
Selling, General & Admin1.04M1.56M1.63M2.15M2.23M
Operating Expenses4.59M8.04M9.32M17.63M19.45M
Depreciation & Amortization3.61K3.61K3.61K3.61K1.78K
EBITDA(4.57M)(7.82M)(8.89M)(17.41M)(19.36M)
EBITDA Margin—————
Operating Income(4.6M)(8.04M)(9.33M)(17.64M)(19.45M)
Operating Margin—————
Interest Income27.37K215.02K436.06K223.01K89.7K
Interest Expense00000
Other Income / Expenses27.37K215.02K436.06K223.01K89.7K
Income Before Tax(4.57M)(7.83M)(8.89M)(17.41M)(19.36M)
Pre-Tax Margin—————
Income Tax Expense00000
Net Income(4.57M)(7.83M)(8.89M)(17.41M)(19.36M)
Net Margin—————
EPS (Basic)(0.35)(0.61)(0.69)(1.21)(1.43)
EPS (Diluted)(0.35)(0.61)(0.69)(1.21)(1.43)
Weighted Avg Shares12.94M12.91M12.85M13.01M13.53M
Weighted Avg Shares (Diluted)12.94M12.91M12.85M13.01M13.53M

Greenwich LifeSciences, Inc.

NASDAQ:GLSI

Intrinsic Alpha fair value

Locked

Current Price

$20.58

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.